Martin Driscoll to Serve as an Adviser to Siva. December 30, 2021 Dr. Swarna Balasubramaniam Joins Siva As a Medical Adviser. June 10, 2021 Siva Receives Patent for SivaLum™ Light Engine.May 16, 2018 Siva Receives US China Innovation Alliance Award and Prepares for Trip to China. May 18, 2018 Siva’s Targeted Hyperthermia™ Accepted for Full Characterization at the Frederick National Laboratory for Cancer Research. July 18, 2018 Siva’s Targeted Hyperthermia™ Program Accepted by the Nanotechnology Characterization Laboratory.July 18, 2018 Siva Therapeutics Initiates Research Collaboration with Plexxikon Inc.January 23, 2014 Siva Therapeutics Completes Efficacy Study in Melanoma Model and Files FDA Pre-Submission. July 10, 2013 Siva Therapeutics Awarded a $250,000 Grant from the State of Colorado.February 4, 2013 Siva Therapeutics Closes Angel Financing Round, Moves into New Facilities.December 3, 2012 Siva Therapeutics Awarded $350,000 Breakout Labs Grant.September 26, 2012 Siva Therapeutics Licenses ‘Smart Polymer’ Technology from Colorado School of Mines. September 6, 2012
